Diane Weiser | VP, Corporate Communications, and IR |
Robert Blum | President and CEO |
Fady Malik | EVP, Research and Development |
Andrew Wolff | SVP and CMO |
Peter Roddy | SVP and CAO |
Ching Jaw | SVP and CFO |
Joseph Pantginis | H.C. Wainwright |
Ishmael Asante | Morgan Stanley |
Jason Butler | JMP Securities |
Chad Messer | Needham & Company |
Edward Tenthoff | Piper Jaffray |
Vernon Bernardino | Seaport Global Securities |
Good afternoon. Welcome, ladies and gentlemen, to the Cytokinetics' Second Quarter 2018 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the call for questions and answers after the presentation. I will now turn the call over to Diane Weiser, Cytokinetics Vice President of Corporate Communications and Investor Relations.